Genmab — Juni 2017
-
Det må man sige. Måske skulle man gå lidt i Bear i morgen.....der er lang tidtil 18.juli.
-
På FB aktiesnak har jeg fundet en Fierce Biotech artikel, der er lagt på d. 22/6 af Kim Willy Christiansen. Det omhandler den nye chef for FDA, og hvad han vil forbedre. For mig ser det ud til, at Dara kan blive godkendt bredt til al cancer med cd 38 på en gang. Det er noget af en drøm, og afhænger jo af, om han kan gennemføre det.
-
"One example is a cancer where a drug targets a particular molecular subset, regardless of where the tumor arises. We`ll clarify when we can give broad approval to a drug in multiple different kinda of molecularli-similar cancers which are not particular to the tumor being in one specific tissue or organ" Gottlieb said.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
